NCT03901209View on ClinicalTrials.gov

First-In-Man Performance and Safety Evaluation of the CARLO® Device in Midface Osteotomies

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

August 28, 2020

Study Completion Date

August 28, 2020

Conditions
Abnormalities, JawMalocclusion, Angle Class III
Interventions
DEVICE

Mid-face osteotomy

The mid-face osteotomy - typically according to LeFort I - is performed using a pulsed erbium-doped yttrium aluminium garnet (Er:YAG) laser driven by the CARLO robot arm.

Trial Locations (4)

1090

Allgemeines Krankenhaus der Stadt Wien (AKH Wien), Vienna

4031

Universitätsspital Basel, Basel

5051

Kantonsspital Aarau AG, Aarau

20246

Universitätsklinikum Hamburg-Eppendorf, Hamburg

All Listed Sponsors
collaborator

Clinical Trial Unit, University Hospital Basel, Switzerland

OTHER

lead

Advanced Osteotomy Tools (AOT) AG

INDUSTRY

NCT03901209 - First-In-Man Performance and Safety Evaluation of the CARLO® Device in Midface Osteotomies | Biotech Hunter | Biotech Hunter